Citing that the retinal examination (fundoscopy) shall be done periodically, the Subject Expert Committee (SEC) functional ...
Medical treatments, including jabs used for weight loss, are monitored in part using the Medicines and Healthcare products ...
Adult and pediatric patients with neurofibromatosis type 1 who have symptomatic plexiform ... dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms ...
Piling into the GLP-1 space There is also continued activity in obesity and diabetes following the runaway success of Novo Nordisk’s Wegovy (semaglutide) and other GLP-1 agonists. Pharma ...
On February 21, 2025, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order determining that the semaglutide ...
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Hims & Hers co-founder and CEO Andrew Dudum said the company will pivot and focus on different offerings such as its ...
Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and other biotech news in today's Readout ...
Following the resolution of Eli Lilly’s tirzepatide shortage in October, the FDA has officially declared an end to the supply ...
The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...